NEW YORK (GenomeWeb) – Danaher today initiated guidance for adjusted diluted EPS for Fiscal Year 2016 in the range of $4.80 to $4.95.

The firm assumed core revenue growth between 2 percent and 3 percent for FY 2016.

The company also reaffirmed adjusted diluted EPS for the fourth quarter of 2015 to be in the range of $1.25 to $1.29. The average Wall Street estimate is for EPS of $1.25 in Q4.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.